tetano
Editor, Senior Moderator
Acad Emerg Med
. 2021 Nov 15.
doi: 10.1111/acem.14417. Online ahead of print.
Higher-Dose Versus Standard-Dose Prophylactic Anticoagulation in Hospitalized Patients with COVID-19
Brit Long[SUP] 1 [/SUP], Michael Gottlieb[SUP] 2 [/SUP]
Affiliations
Abstract
Coronavirus 2019 (COVID-19) is a global pandemic, which has resulted in over 230 million cases and 4.7 million deaths as of September 25, 2021.[SUP]1,2[/SUP] Literature suggests those with moderate or severe disease have increased endothelial activation and inflammation, coagulopathy, and elevated D-dimer levels, which may increase thromboembolic events.[SUP]2-4[/SUP].
Keywords: COVID-19; anticoagulation; hematology; infectious diseases.
. 2021 Nov 15.
doi: 10.1111/acem.14417. Online ahead of print.
Higher-Dose Versus Standard-Dose Prophylactic Anticoagulation in Hospitalized Patients with COVID-19
Brit Long[SUP] 1 [/SUP], Michael Gottlieb[SUP] 2 [/SUP]
Affiliations
- PMID: 34779548
- DOI: 10.1111/acem.14417
Abstract
Coronavirus 2019 (COVID-19) is a global pandemic, which has resulted in over 230 million cases and 4.7 million deaths as of September 25, 2021.[SUP]1,2[/SUP] Literature suggests those with moderate or severe disease have increased endothelial activation and inflammation, coagulopathy, and elevated D-dimer levels, which may increase thromboembolic events.[SUP]2-4[/SUP].
Keywords: COVID-19; anticoagulation; hematology; infectious diseases.